• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过非内体途径将mRNA体外递送至免疫细胞可避免核苷修饰的需求。

Ex Vivo Delivery of mRNA to Immune Cells via a Nonendosomal Route Obviates the Need for Nucleoside Modification.

作者信息

Ghoshal Bartika, Chakraborty Debajyoti, Nag Manish, Varadarajan Raghavan, Jhunjhunwala Siddharth

机构信息

Department of Bioengineering, Indian Institute of Science, Bengaluru 560012, India.

Molecular Biophysics Unit, Indian Institute of Science, Bengaluru 560012, India.

出版信息

ACS Bio Med Chem Au. 2024 Nov 12;4(6):291-299. doi: 10.1021/acsbiomedchemau.4c00057. eCollection 2024 Dec 18.

DOI:10.1021/acsbiomedchemau.4c00057
PMID:39712209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11659889/
Abstract

Base modification and the use of lipid nanoparticles are thought to be essential for efficient in vivo delivery and expression of mRNA. However, for ex vivo immune cell engineering, the need for either of the two is unclear. Previous reports have suggested that nucleic acids may be efficiently delivered to immune cells ex vivo, through a nonendosomal delivery route, but the need for base modification has not been determined. Herein, we demonstrate that when a nonendosomal delivery method is used, unmodified mRNA performs equally well to the commonly used base-modified mRNA, including the methyl pseudouridine modification, in terms of protein expression and inflammatory response in cells. However, if an endosomal delivery route is used, then methyl pseudouridine modification is necessary for high expression and low inflammatory response, as demonstrated by others as well. Overall, we show that nonendosomal mRNA delivery renders nucleoside modifications nonessential and that unmodified mRNA combined with nonendosomal delivery route may be used for efficient ex vivo mRNA-based engineering of immune cells.

摘要

碱基修饰和脂质纳米颗粒的使用被认为是实现mRNA在体内高效递送和表达所必需的。然而,对于离体免疫细胞工程而言,这两者中任何一个的必要性尚不清楚。先前的报告表明,核酸或许可以通过非内体递送途径有效地离体递送至免疫细胞,但碱基修饰的必要性尚未确定。在此,我们证明,当使用非内体递送方法时,就细胞中的蛋白质表达和炎症反应而言,未修饰的mRNA与常用的碱基修饰mRNA(包括N1-甲基假尿苷修饰)表现相当。然而,正如其他人所证明的那样,如果使用内体递送途径,那么N1-甲基假尿苷修饰对于高表达和低炎症反应是必要的。总体而言,我们表明非内体mRNA递送使得核苷修饰不再必要,并且未修饰的mRNA与非内体递送途径相结合可用于基于mRNA的高效离体免疫细胞工程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b6/11659889/32b20aa28c4a/bg4c00057_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b6/11659889/fd1994b6597a/bg4c00057_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b6/11659889/4dd00887b40d/bg4c00057_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b6/11659889/64598cdd8a0c/bg4c00057_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b6/11659889/42e2ac8cd729/bg4c00057_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b6/11659889/247d87796e98/bg4c00057_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b6/11659889/32b20aa28c4a/bg4c00057_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b6/11659889/fd1994b6597a/bg4c00057_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b6/11659889/4dd00887b40d/bg4c00057_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b6/11659889/64598cdd8a0c/bg4c00057_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b6/11659889/42e2ac8cd729/bg4c00057_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b6/11659889/247d87796e98/bg4c00057_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b6/11659889/32b20aa28c4a/bg4c00057_0006.jpg

相似文献

1
Ex Vivo Delivery of mRNA to Immune Cells via a Nonendosomal Route Obviates the Need for Nucleoside Modification.通过非内体途径将mRNA体外递送至免疫细胞可避免核苷修饰的需求。
ACS Bio Med Chem Au. 2024 Nov 12;4(6):291-299. doi: 10.1021/acsbiomedchemau.4c00057. eCollection 2024 Dec 18.
2
Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.体内研究未修饰和假尿嘧啶修饰的 mRNA 经脂质纳米粒系统给药的疗效和免疫原性。
Biomaterials. 2016 Dec;109:78-87. doi: 10.1016/j.biomaterials.2016.09.006. Epub 2016 Sep 25.
3
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery.脂质纳米颗粒化学决定了核苷碱基修饰如何改变 mRNA 的递送。
J Control Release. 2022 Jan;341:206-214. doi: 10.1016/j.jconrel.2021.11.022. Epub 2021 Nov 18.
4
The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines.假尿苷对新冠病毒mRNA疫苗的关键作用
Front Cell Dev Biol. 2021 Nov 4;9:789427. doi: 10.3389/fcell.2021.789427. eCollection 2021.
5
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.用于向 T 细胞递 mRNA 的可离子化脂质纳米粒中的羟胆固醇取代。
J Control Release. 2022 Jul;347:521-532. doi: 10.1016/j.jconrel.2022.05.020. Epub 2022 May 23.
6
The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system.信使核糖核酸(mRNA)疫苗中核苷酸碱基修饰的影响受其脂质纳米颗粒递送系统化学性质的影响。
Mol Ther Nucleic Acids. 2023 May 8;32:794-806. doi: 10.1016/j.omtn.2023.05.004. eCollection 2023 Jun 13.
7
Sensitive and quantitative probing of pseudouridine modification in mRNA and long noncoding RNA.灵敏且定量探测 mRNA 和长非编码 RNA 中的假尿嘧啶修饰。
RNA. 2019 Sep;25(9):1218-1225. doi: 10.1261/rna.072124.119. Epub 2019 Jun 21.
8
Development and Evaluation of the Immunogenic Potential of an Unmodified Nucleoside mRNA Vaccine for Herpes Zoster.一种未修饰核苷mRNA带状疱疹疫苗免疫原性潜力的开发与评估
Vaccines (Basel). 2025 Jan 13;13(1):68. doi: 10.3390/vaccines13010068.
9
Base-modified factor VIII mRNA delivery with galactosylated lipid nanoparticles as a protein replacement therapy for haemophilia A.用半乳糖化脂质纳米粒递送碱基修饰的因子 VIII mRNA 作为血友病 A 的蛋白替代治疗。
Biomater Sci. 2024 Sep 25;12(19):5052-5062. doi: 10.1039/d4bm00909f.
10
Discovery and characterization of a peptide that enhances endosomal escape of delivered proteins in vitro and in vivo.发现并鉴定一种可增强体外和体内递送蛋白的内体逃逸的肽。
J Am Chem Soc. 2015 Nov 11;137(44):14084-93. doi: 10.1021/jacs.5b05694. Epub 2015 Oct 30.

本文引用的文献

1
Inhalable mRNA Nanoparticle with Enhanced Nebulization Stability and Pulmonary Microenvironment Infiltration.吸入型 mRNA 纳米颗粒,具有增强的雾化稳定性和肺部微环境渗透能力。
ACS Nano. 2024 Sep 3;18(35):24204-24218. doi: 10.1021/acsnano.4c05653. Epub 2024 Aug 22.
2
Low-Dose Mildronate-Derived Lipidoids for Efficient mRNA Vaccine Delivery with Minimal Inflammation Side Effects.低剂量米力农衍生脂质体用于高效 mRNA 疫苗传递,最小化炎症副作用。
ACS Nano. 2024 Aug 27;18(34):23289-23300. doi: 10.1021/acsnano.4c06160. Epub 2024 Aug 16.
3
Targeting Recycling Endosomes to Potentiate mRNA Lipid Nanoparticles.
靶向再循环内体以增强 mRNA 脂质纳米颗粒。
Nano Lett. 2024 May 1;24(17):5104-5109. doi: 10.1021/acs.nanolett.3c04415. Epub 2024 Apr 19.
4
Endosomal escape: A bottleneck for LNP-mediated therapeutics.内涵体逃逸:LNP 介导治疗的瓶颈。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307800120. doi: 10.1073/pnas.2307800120. Epub 2024 Mar 4.
5
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications.用于体内 RNA 递送的脂质纳米颗粒 (LNPs) 及其未来应用的突破性技术。
Adv Drug Deliv Rev. 2023 Sep;200:114990. doi: 10.1016/j.addr.2023.114990. Epub 2023 Jul 7.
6
Delivering the next generation of cancer immunotherapies with RNA.用 RNA 传递下一代癌症免疫疗法。
Cell. 2023 Apr 13;186(8):1535-1540. doi: 10.1016/j.cell.2023.02.031.
7
N-methylpseudouridine-incorporated mRNA enhances exogenous protein expression and suppresses immunogenicity in primary human fibroblast-like synoviocytes.N-甲基假尿苷掺入的mRNA增强了原代人成纤维细胞样滑膜细胞中外源蛋白的表达并抑制了免疫原性。
Cytotechnology. 2022 Aug;74(4):503-514. doi: 10.1007/s10616-022-00540-4. Epub 2022 Jun 30.
8
Chemical modification of uridine modulates mRNA-mediated proinflammatory and antiviral response in primary human macrophages.尿苷的化学修饰可调节原代人巨噬细胞中mRNA介导的促炎和抗病毒反应。
Mol Ther Nucleic Acids. 2022 Jan 10;27:854-869. doi: 10.1016/j.omtn.2022.01.004. eCollection 2022 Mar 8.
9
The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines.假尿苷对新冠病毒mRNA疫苗的关键作用
Front Cell Dev Biol. 2021 Nov 4;9:789427. doi: 10.3389/fcell.2021.789427. eCollection 2021.
10
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.一种用于治疗实验性自身免疫性脑脊髓炎的非炎症性 mRNA 疫苗。
Science. 2021 Jan 8;371(6525):145-153. doi: 10.1126/science.aay3638.